Sven Francque
655 works · 39,929 citations · h-index 82
Top works
- Baveno VII – Renewing consensus in portal hypertension
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
- A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- Advancing the global public health agenda for NAFLD: a consensus statement
- A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆